Fig. 3From: Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusionTime to achievement of 20/40 or better vision by baseline subretinal fluid status. Excludes 22 (10.9%) patients with 20/40 or better vision at baseline; subretinal fluid (presence or absence) by the digital angiography reading center was evaluated using spectral-domain optical coherence tomographyBack to article page